Taking people in FranceNo phase
Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty
Key facts
- Who runs it
- Dedienne Sante S.A.S.
- Where
- Beaumont, Marmande, Montredon-des-Corbières, Nîmes, Péronne, Perpignan, Saint-Etienne, Toulon, and Vantoux, FranceSee the 9 sites
- Trial code
- Status
- Recruiting
- People taking part
- 747 people, planned
- Started
- 21 Sept 2021
- Expected to end
- Sept 2034
- Type of study
- Observational
- Treatments tested
- Total hip arthroplasty (primary or revision)
- Record updated
- 27 August 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient age > 18 years at implantation
- Patient who will undergo, during the study's period of inclusion, a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device (DEDIENNE Santé)
- Patient informed of his/her participation and willing to participate in the study
- Patient able to read, write and understand French
Who cannot take part
- Patient deprived of freedom, under guardianship/curatorship or placed under judicial protection
- Patient unable to follow study procedures
- Patient who has already been included in the study for a total hip arthroplasty (primary or revision) with at least one SYMBOL medical device
Where in France
- Hôpital Privé de la ChâtaigneraieBeaumont, FranceContact: Marion BurlandTaking people
- CH de Marmande - CHICMarmande, FranceContact: Marion BurlandNo longer taking part
- Hôpital Privé du Grand NarbonneMontredon-des-Corbières, FranceContact: Marion BurlandTaking people
- Polyclinique Grand SudNîmes, FranceContact: Marion BurlandTaking people
- CH de PéronnePéronne, FranceContact: Marion BurlandTaking people
- Clinique Mutualiste CatalanePerpignan, FranceContact: Marion BurlandTaking people
- Clinique MutualisteSaint-Etienne, FranceContact: Marion BurlandTaking people
- Hôpital d'Instruction des Armées Saint-AnneToulon, FranceContact: Marion BurlandTaking people
- Hôpital Robert Schuman-UNEOSVantoux, FranceContact: Marion BurlandTaking people
About the trial
What the trial wants to find out
The purpose of this post-market clinical follow up study is to assess the safety and effectiveness of the SYMBOL range of medical devices. The study will evaluate the outcome of Total Hip Arthroplasty using medical devices from SYMBOL range over a period of 10 years.
The group in the trial
- SYMBOL medical devices
Patients undergoing total hip arthroplasty with at least one medical device from the SYMBOL range
Treatment: Total hip arthroplasty (primary or revision)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 27 August 2024